Abstract
In 1972, the Food and Drug Administration (FDA) granted regulatory approval for xylazine hydrochloride, a sedative intended for use in animals. This particular drug continues to hold significance for veterinarians specializing in the care of large animals such as horses, cattle, and deer
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have